31-03-238

An Open-label Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered Aripiprazole Tablets in Children and Adolescent Patients

Study Information Study ID

31-03-238/NCT00102479

Full Study Title

An Open-label Dose Escalation Study to Assess the Safety, Tolerability and Pharmacokinetics of Orally Administered Aripiprazole Tablets in Children and Adolescent Patients

Active Ingredient / Drug Information

Aripiprazole/Tablet, Oral

Disease

Schizophrenia and Acute Mania

Phase

CSR Summary

31-03-238 Clinical Summary.pdf